NCT06364293

Brief Summary

Endovascular treatment has become one of the primary treatment methods for intracranial aneurysms. The unfavorable outcomes during follow-up included aneurysm recurrence and long-term incomplete-occlusion, which would bring a high risk of rebleeding and retreatment. Previous studies have tried to predict the outcomes of aneurysms following endovascular treatment based on aneurysm characteristics including morphology, embolization packing degree, etc, but the conclusion was inconsistent. Hemodynamics of aneurysms and parent artery played a greater role in predicting outcomes following endovascular treatments. Investigators also found that the outcomes were determined by many factors, in which the demography, clinical indicators, treatment methods, and material selection can not be ignored, and the mechanism of unfavorable imaging outcomes should be explored using large samples of clinical cases and numerous variable parameters. The pre-experiment of investigators confirmed that artificial intelligence technology can meet the calculation requirements for deep mining and analysis of large sample data. This study aims to use the deep learning model to identify relevant risk factors and weights, establish a stable and accurate prediction model, then incorporate the prospective study to verify the model. The results will be very helpful in accurately predicting the adverse outcomes such as recurrence and long-term non-occlusion after endovascular treatment and help to improve the therapeutic strategy and avoid risk factors. Besides, the occurrence of ischemic or hemorrhagic complications during follow-up may affect the final follow-up outcome, so the analysis was included as one of the outcome events to evaluate the prognosis after intervention.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
750

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Jan 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Jan 2024Dec 2026

Study Start

First participant enrolled

January 1, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 3, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 15, 2024

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

April 15, 2024

Status Verified

April 1, 2024

Enrollment Period

3 years

First QC Date

April 3, 2024

Last Update Submit

April 11, 2024

Conditions

Keywords

Unfavorable imaging outcomeartificial intelligent prediction modelDeep learning

Outcome Measures

Primary Outcomes (1)

  • Unfavorable imaging outcome

    Unfavorable imaging outcome included the recurrence and long-term incomplete aneurysm occlusion. Any enlarged imaging of the residual portion of the aneurysm is considered a recurrence compared to immediate postoperative imaging. At the last DSA follow-up longer than 12 months, the aneurysm was not completely occluded, showing aneurysm residual portion and development (Raymond scale 3) and was judged to be long-term incomplete aneurysm occlusion.)

    through study completion, an average of 1 year

Secondary Outcomes (1)

  • Hemorrhagic or ischemic complication occurred during the follow-up

    through study completion, an average of 1 year

Study Arms (1)

the cohort with or without unfavorable imaging outcome

Cohorts will be divided into the favorable imaging outcome group and unfavorable imaging outcome group according to the interpretation of the imaging outcome of the postoperative follow-up of intravascular interventional therapy for intracranial aneurysms

Other: Observational design does not include interventional behavior.

Interventions

Observational design does not include interventional behavior.

the cohort with or without unfavorable imaging outcome

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study included the patients undergoing intravascular interventional treatment of intracranial aneurysms.

You may qualify if:

  • Clinical diagnosis of intracranial aneurysm;
  • Endovascular intervention was performed;
  • The age is more than 18 years and less than 80 years;
  • At least one follow-up of imaging data must be digital subtraction angiography with a time interval of 12 months or more;
  • The quality of image data can satisfy morphological measurement and hemodynamic calculation;
  • The patient family members were informed and consented to participate in the study.

You may not qualify if:

  • Dynamic aneurysms with cerebrovascular malformation;
  • Dissecting, fusiform or thrombotic aneurysms;
  • Follow-up images were not digital subtraction angiography or data quality can not meet the hydrodynamic analysis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tiantan hospital

Beijing, China

Location

MeSH Terms

Conditions

Intracranial Aneurysm

Condition Hierarchy (Ancestors)

Intracranial Arterial DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAneurysmVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2024

First Posted

April 15, 2024

Study Start

January 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 15, 2024

Record last verified: 2024-04

Locations